ZA945418B - Method of inhibiting the replication of human immunodeficiency viruses (HIV) in HIV seropositive humans. - Google Patents

Method of inhibiting the replication of human immunodeficiency viruses (HIV) in HIV seropositive humans.

Info

Publication number
ZA945418B
ZA945418B ZA945418A ZA945418A ZA945418B ZA 945418 B ZA945418 B ZA 945418B ZA 945418 A ZA945418 A ZA 945418A ZA 945418 A ZA945418 A ZA 945418A ZA 945418 B ZA945418 B ZA 945418B
Authority
ZA
South Africa
Prior art keywords
hiv
replication
inhibiting
human immunodeficiency
immunodeficiency viruses
Prior art date
Application number
ZA945418A
Other languages
English (en)
Inventor
Alison Mary Badger
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA945418B publication Critical patent/ZA945418B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA945418A 1993-07-23 1994-07-22 Method of inhibiting the replication of human immunodeficiency viruses (HIV) in HIV seropositive humans. ZA945418B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939315340A GB9315340D0 (en) 1993-07-23 1993-07-23 Methods

Publications (1)

Publication Number Publication Date
ZA945418B true ZA945418B (en) 1995-05-10

Family

ID=10739357

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA945418A ZA945418B (en) 1993-07-23 1994-07-22 Method of inhibiting the replication of human immunodeficiency viruses (HIV) in HIV seropositive humans.

Country Status (9)

Country Link
EP (1) EP0711160A4 (fr)
JP (1) JPH09500648A (fr)
CN (1) CN1130871A (fr)
AU (1) AU7370994A (fr)
CA (1) CA2167842A1 (fr)
GB (1) GB9315340D0 (fr)
NZ (1) NZ269991A (fr)
WO (1) WO1995003042A1 (fr)
ZA (1) ZA945418B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9315351D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315306D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato
AU710542B2 (en) * 1996-05-17 1999-09-23 Anormed Inc. Use of substituted azaspirane in the treatment of asthma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
GB9201804D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Corp Methods
GB9201803D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Corp Methods
GB9315298D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315351D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315306D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods

Also Published As

Publication number Publication date
EP0711160A4 (fr) 1998-09-09
AU7370994A (en) 1995-02-20
JPH09500648A (ja) 1997-01-21
EP0711160A1 (fr) 1996-05-15
CN1130871A (zh) 1996-09-11
WO1995003042A1 (fr) 1995-02-02
CA2167842A1 (fr) 1995-02-02
GB9315340D0 (en) 1993-09-08
NZ269991A (en) 1999-07-29

Similar Documents

Publication Publication Date Title
EP0676954A4 (fr) Leurre de virus de l'immunodeficience humaine.
EP0630630A3 (fr) Sous-vêtement à jeter.
LTIP335A (en) Vaccine for human immunodeficiency virus
AU2419595A (en) Recombinant human immunodeficiency virus vector and process for producing the same
EP0853662A4 (fr) Nouveau clone proviral du virus de l'immunodeficience humaine de type 2 (hiv-2) a possibilite de replication, appele hiv-2kr
ZA964679B (en) Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection.
FI932847A0 (fi) HIV-proteasinhibitorer som aer anvaendbara foer behandling av aids
AU5686196A (en) Use of an "immunodeficiency-virus suppressing lymphokine (ISL)" to inhibit the replication of viruses, in particular of retroviruses
ZA943917B (en) Virus resistant plants
IL109437A0 (en) 2-Amino-4-quinolyldihydropyridines, processes for their preparation and their use
EP0648430A3 (fr) Orge à cuisson rapide et procédé de préparation.
ZA945418B (en) Method of inhibiting the replication of human immunodeficiency viruses (HIV) in HIV seropositive humans.
HU9403135D0 (en) Cyclic-acetals, process for their preparation and them use as herbicide
ZA945416B (en) Method of inhibiting the production of infectious human immunodeficiency viruses (HIV) in HIV seropositive humans.
EP0630631A3 (fr) Sous-vêtement à jeter.
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
IL110967A0 (en) Substituted tetronic acids useful for treating hiv and other retroviruses
NO903801D0 (no) Alkalipullunase, mikroorganisme og fremgangsmaate ved fremstilling derav.
EP0603965A3 (en) Modified block copolymers and process for the preparation thereof.
ZA945417B (en) Method of inhibiting cellular entry of human immunodeficiency viruses NHIV) in HIV seropositive humans.
EP0674657A4 (fr) Gp41 mutants et leur utilisation comme agents therapeutiques contre le vih.
HUT69285A (en) Ethanolamine derivatives, pharmaceutical compns. contg. them and process to prepare the sald compds.
WO1993014760A3 (fr) Procedes
AU5000796A (en) Process for the deactivation of hiv and other viruses
AU1249492A (en) Removing metal from composite bodies, and resulting products